Augmentation with Buspirone: A Review

REFERENCES

• Eison AS, Temple DL: Buspirone: Review of its pharmacol-ogy and current perspectives on its mechanism of action. Am J Med 1986; 80 (Suppl, 3B):1–9.
   Google Scholar
• RiekeIs K, Weisman K, Norstad N, Singer M, Stoltz D, Brown A, Danton J: Buspirone and diazepam in anxiety: A control-led study. .1 Clin Psychiatry 1982; 43:81–86
   Google Scholar
• Pohl R, Balon R, Yeragani VK, Gershon S: Serotonergic anx-iolytics in the treatment of panic disorder: A controlled study with buspirone. Psychopathology 1989; 22 (Suppl 1):60–67
   Google Scholar
• Sheehan DV, Raj AB, Harnett-Sheehan K, Soto S: The rela-tive efficacy of buspirone, imipramine and placebo in panic disorder: A preliminary report. Psychopharmacol, Biochem and Behav 1988; 29:815–817
   PubMed Web of Science ®Google Scholar
• Schweizer E, Amsterdam J, Riekels K, Kaplan M, Droba M: Open trial of buspirone in the treatment of major depressive disorder. Psychopharmacol Bull 1986; 22(1): 183–185
   Google Scholar
• Rickels K, Amsterdam JD, Clary C, Puzzuoli G, Schweizer E: Buspirone in major depression: A controlled study. J Clin Psychiatry 1991; 12:34–38
   Google Scholar
• Robinson DS, Riekels K, Feighner J, Fabre LF, Gammans RE, Shrotriya RC, Alms DR, Andary JJ, Messina ME: Clini-cal effects of 5HTIA partial agonists in depression: A com-posite analysis of buspirone in the treatment of depression. J Clin Psychopharmacol 1990; 10:67S–76S
   Google Scholar
• Pato MT, Pigott TA, Hill JL, Grover GN, Bernstein S, Mur-phy DL: Controlled comparison of buspirone and clomi-pramine in obsessive-compulsive disorder. Am J Psychiatry 1991; 148:127–129
   PubMed Web of Science ®Google Scholar
• Sathananthan GL, Sanghvi I, Phillips N, Gershon S: MJ9022: Correlation between neuroleptic potential and stereotypy. Curr Ther Res 1975; 18:701–705
   PubMed Web of Science ®Google Scholar
• Markovitz PJ, Stagno SJ, Calabrese JR: Buspirone augmen-tation of fluoxetine in obsessive-compulsive disorder. Am J Psychiatry 1990; 147:798–800
   PubMed Web of Science ®Google Scholar
• Jenike MA, Baer L, Buttolph L: Buspirone augmentation of fluoxetine in patients with obsessive-compulsive disorder. J Clin Psychiatry 1991; 52:13–14
   PubMed Web of Science ®Google Scholar
• Pigott TA, L'Heureux F, Hill JL, Bihari K, Bernstein SE, Murphy DL: A double-blind study of adjuvant buspirone hy-drochloride in clomipramine-treated patients with obsessive-compulsive disorder. J Clin Psychopharmacol 1992; 12:11–18
   PubMed Web of Science ®Google Scholar
• McDougle CJ, Goodman WK, Leckman JF, Holzer JC, Barr LC, McCance-Katz E, Heninger GR, Price LH: Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder. Am J Psychiatry 1993; 150:647–649
   PubMed Web of Science ®Google Scholar
• Grady TA, Pigott TA, L'Heureux F, Hill JL, Bernstein SE, Murphy DL: Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disor-der. Am J Psychiatry 1993; 150:819–821
   PubMed Web of Science ®Google Scholar
• Gastfriend DR, Rosenbaum JF: Adjunctive buspirone in ben-zodiazepine treatment of four patients with panic disorder. Am J Psychiatry 1989; 146:914–916
   Google Scholar
• Jacobsen FM: Possible augmentation of antidepressant re-sponse by buspirone. J Clin Psychiatry 1991; 52:217–220
   Google Scholar
• Joffe RT, Schuller DR: An open study of buspirone augmen-tation of serotonin reuptake inhibitors in refractory depres-sion. J Clin Psychiatry 1993; 54:269–271
   PubMed Web of Science ®Google Scholar
• Goff DC, Midha KK, Brotman AW, McCormick S, Waites M, Amico ET: An open trial of buspirone added to neurolep-tics in schizophrenic patients. J Clin Psychopharmacol 1991; 11:193–197
   PubMed Web of Science ®Google Scholar
• D'Mello DA, McNeil JA, Harris W: Buspirone suppression of neuroleptic-induced akathisia: Multiple case reports. J Clin Psychopharmacol 1989; 9:151–152
   Google Scholar
• Brody D, Adler LA, Kim T, Angrist B, Rotrosen J: Effects of buspirone in seven schizophrenic subjects. J Clin Psycho-pharmacol 1990; 10:68–69
   Google Scholar
• Sovner R, Parnell-Sovner N: Use of buspirone in the treat-ment of schizophrenia. J Clin Psychopharmacol 1989; 9:61–62
   Google Scholar
• Liegghio NE, Yeragani VK: Buspirone-induced hypomania: A case report. J Clin Psychopharmacol 1988; 8:226–227
   Google Scholar
• McDaniel JS, Ninan PT, Magnuson JV: Possible induction of mania by buspirone. Am J Psychiatry 1990; 147:125–126
   Google Scholar
• Price WA, Bielefeld M: Buspirone-induced mania. J Clin Psy-chopharmacol 1989; 9:150–151
   Google Scholar
• Lebert F, Pasquier F, Goudemand M, Petit H: Euphoria with buspirone after fluoxetine treatment. Am J Psychiatry 1993; 150:167
   Google Scholar
• Goldberg RJ, Huk M: Serotonin syndrome from trazodone and buspirone. Psychosomatics 1992; 33:235–236
   PubMedGoogle Scholar
• Boylan K: Persistent dystonia associated with buspirone. Neu-rology 1990; 40:1904
   Google Scholar
• Ritchie EC, Bridenbaugh RH, Jabbari B: Acute generalized myoclonus following buspirone administration. J Clin Psy-chiatry 1988; 49:242–243
   Google Scholar
• Strauss A: Oral dyskinesia associated with buspirone use in an elderly woman. J Clin Psychiatry 1988; 49:322–323
   Google Scholar
• Patterson JF: Akathisia associated with buspirone. J Clin Psy-chopharmacol 1988; 8:296–297
   Google Scholar
• Moss LE, Neppe VM, Drevets WC: Buspirone in the treat-ment of tardive dyskinesia. J Clin Psychopharmacol 1993; 13:204–209
   PubMed Web of Science ®Google Scholar
• Norden Mk Buspirone treatment of sexual dysfunction asso-ciated with selective serotonin re-uptake inhibitors. Depres-sion 1994; 2:109–112
   Google Scholar